• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆代谢组学揭示肺腺癌的危险因素。

Plasma metabolomics reveals risk factors for lung adenocarcinoma.

作者信息

Yu Mengjie, Wen Wei, Wang Yue, Shan Xia, Yi Xin, Zhu Wei, Aa Jiye, Wang Guangji

机构信息

Key Laboratory of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, Nanjing, Jiangsu, China.

Department of Thoracic Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

出版信息

Front Oncol. 2024 Mar 19;14:1277206. doi: 10.3389/fonc.2024.1277206. eCollection 2024.

DOI:10.3389/fonc.2024.1277206
PMID:38567154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10985191/
Abstract

BACKGROUND

Metabolic reprogramming plays a significant role in the advancement of lung adenocarcinoma (LUAD), yet the precise metabolic changes remain incompletely understood. This study aims to uncover metabolic indicators associated with the progression of LUAD.

METHODS

A total of 1083 subjects were recruited, including 670 LUAD, 135 benign lung nodules (BLN) and 278 healthy controls (HC). Gas chromatography-mass spectrometry (GC/MS) was used to identify and quantify plasma metabolites. Odds ratios (ORs) were calculated to determine LUAD risk factors, and machine learning algorithms were utilized to differentiate LUAD from BLN.

RESULTS

High levels of oxalate, glycolate, glycine, glyceric acid, aminomalonic acid, and creatinine were identified as risk factors for LUAD (adjusted ORs>1.2, P<0.03). Remarkably, oxalate emerged as a distinctive metabolic risk factor exhibiting a strong correlation with the progression of LUAD (adjusted OR=5.107, P<0.001; advanced-stage vs. early-stage). The Random Forest (RF) model demonstrated a high degree of efficacy in distinguishing between LUAD and BLN (accuracy = 1.00 and 0.73, F1-score= 1.00 and 0.79, and AUC = 1.00 and 0.76 in the training and validation sets, respectively). TCGA and GTEx gene expression data have shown that lactate dehydrogenase A (LDHA), a crucial enzyme involved in oxalate metabolism, is increasingly expressed in the progression of LUAD. High LDHA expression levels in LUAD patients are also linked to poor prognoses (HR=1.66, 95% CI=1.34-2.07, P<0.001).

CONCLUSIONS

This study reveals risk factors associated with LUAD.

摘要

背景

代谢重编程在肺腺癌(LUAD)进展中起重要作用,但确切的代谢变化仍未完全明确。本研究旨在揭示与LUAD进展相关的代谢指标。

方法

共招募1083名受试者,包括670例LUAD、135例良性肺结节(BLN)和278例健康对照(HC)。采用气相色谱 - 质谱联用(GC/MS)技术鉴定和定量血浆代谢物。计算比值比(OR)以确定LUAD危险因素,并利用机器学习算法区分LUAD与BLN。

结果

草酸盐、乙醇酸盐、甘氨酸、甘油酸、氨基丙二酸和肌酐水平升高被确定为LUAD的危险因素(校正OR>1.2,P<0.03)。值得注意的是,草酸盐成为一种独特的代谢危险因素,与LUAD进展密切相关(校正OR = 5.107,P<0.001;晚期与早期相比)。随机森林(RF)模型在区分LUAD和BLN方面显示出高度有效性(训练集和验证集中的准确率分别为1.00和0.73,F1分数分别为1.00和0.79,AUC分别为1.00和0.76)。TCGA和GTEx基因表达数据表明,乳酸脱氢酶A(LDHA)是草酸盐代谢中的关键酶,在LUAD进展中表达增加。LUAD患者中高LDHA表达水平也与不良预后相关(HR = 1.66,95%CI = 1.34 - 2.07,P<0.001)。

结论

本研究揭示了与LUAD相关的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/618a97e34cef/fonc-14-1277206-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/5b80b7b0e932/fonc-14-1277206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/c683208850d3/fonc-14-1277206-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/4a5a1fea838c/fonc-14-1277206-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/ac278f18dc4f/fonc-14-1277206-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/36b72033b826/fonc-14-1277206-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/0f0ea6388f71/fonc-14-1277206-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/618a97e34cef/fonc-14-1277206-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/5b80b7b0e932/fonc-14-1277206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/c683208850d3/fonc-14-1277206-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/4a5a1fea838c/fonc-14-1277206-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/ac278f18dc4f/fonc-14-1277206-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/36b72033b826/fonc-14-1277206-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/0f0ea6388f71/fonc-14-1277206-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134f/10985191/618a97e34cef/fonc-14-1277206-g007.jpg

相似文献

1
Plasma metabolomics reveals risk factors for lung adenocarcinoma.血浆代谢组学揭示肺腺癌的危险因素。
Front Oncol. 2024 Mar 19;14:1277206. doi: 10.3389/fonc.2024.1277206. eCollection 2024.
2
A metabolomics study on carcinogenesis of ground-glass nodules.磨玻璃结节癌变的代谢组学研究
Cytojournal. 2024 Mar 18;21:12. doi: 10.25259/Cytojournal_68_2023. eCollection 2024.
3
Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.早期肺腺癌中一种稳健的免疫相关预后标志物的开发与验证
J Transl Med. 2020 Oct 7;18(1):380. doi: 10.1186/s12967-020-02545-z.
4
Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing.联合抑制丙酮酸脱氢酶激酶 1 和乳酸脱氢酶 a 可诱导代谢和信号重编程,并增强肺腺癌细胞杀伤作用。
Cancer Lett. 2023 Nov 28;577:216425. doi: 10.1016/j.canlet.2023.216425. Epub 2023 Oct 5.
5
Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.使用机器学习方法探索肺腺癌中预测性和预后性可变剪接特征
J Transl Med. 2020 Dec 7;18(1):463. doi: 10.1186/s12967-020-02635-y.
6
Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes.基于代谢基因生物信息学分析构建肺腺癌预后模型
Transl Cancer Res. 2020 May;9(5):3518-3538. doi: 10.21037/tcr-20-1571.
7
Comprehensive Analysis and Reinforcement Learning of Hypoxic Genes Based on Four Machine Learning Algorithms for Estimating the Immune Landscape, Clinical Outcomes, and Therapeutic Implications in Patients With Lung Adenocarcinoma.基于四种机器学习算法的低氧基因综合分析与强化学习,用于评估肺腺癌患者的免疫景观、临床结局和治疗意义。
Front Immunol. 2022 Jun 10;13:906889. doi: 10.3389/fimmu.2022.906889. eCollection 2022.
8
Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.基于 13 种程序性细胞死亡模式的机器学习对肺腺癌患者预后和治疗反应预测的分子亚型。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11351-11368. doi: 10.1007/s00432-023-05000-w. Epub 2023 Jun 28.
9
Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma.早期肺腺癌中与临床结局相关的免疫景观和新型免疫治疗相关基因特征。
J Mol Med (Berl). 2020 Jun;98(6):805-818. doi: 10.1007/s00109-020-01908-9. Epub 2020 Apr 25.
10
[Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].[肺腺癌自噬相关基因预后风险评分模型的构建与验证]
Zhongguo Fei Ai Za Zhi. 2021 Aug 20;24(8):557-566. doi: 10.3779/j.issn.1009-3419.2021.103.09. Epub 2021 Jul 14.

引用本文的文献

1
Metabolomics for early-stage lung adenocarcinoma: diagnostic biomarker screening.早期肺腺癌的代谢组学:诊断生物标志物筛查
Front Oncol. 2025 Mar 11;15:1535525. doi: 10.3389/fonc.2025.1535525. eCollection 2025.
2
Novel Spatial Approaches to Dissect the Lung Cancer Immune Microenvironment.剖析肺癌免疫微环境的新型空间方法
Cancers (Basel). 2024 Dec 12;16(24):4145. doi: 10.3390/cancers16244145.
3
Metabolomic profiling of childhood medulloblastoma: contributions and relevance to diagnosis and molecular subtyping.儿童髓母细胞瘤的代谢组学分析:对诊断和分子分型的贡献和相关性。

本文引用的文献

1
Oxalate homeostasis.草酸盐稳态。
Nat Rev Nephrol. 2023 Feb;19(2):123-138. doi: 10.1038/s41581-022-00643-3. Epub 2022 Nov 3.
2
Integrative Serum Metabolic Fingerprints Based Multi-Modal Platforms for Lung Adenocarcinoma Early Detection and Pulmonary Nodule Classification.基于整合血清代谢指纹的多模态平台用于肺腺癌早期检测和肺结节分类。
Adv Sci (Weinh). 2022 Dec;9(34):e2203786. doi: 10.1002/advs.202203786. Epub 2022 Oct 18.
3
The multiple roles of LDH in cancer.LDH 在癌症中的多重作用。
J Cancer Res Clin Oncol. 2024 Oct 23;150(10):471. doi: 10.1007/s00432-024-05990-1.
Nat Rev Clin Oncol. 2022 Dec;19(12):749-762. doi: 10.1038/s41571-022-00686-2. Epub 2022 Oct 7.
4
Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma.基于肺腺癌谷氨酰胺代谢预测预后、免疫原性和免疫治疗疗效。
Front Immunol. 2022 Aug 11;13:960738. doi: 10.3389/fimmu.2022.960738. eCollection 2022.
5
Identification of Two Subtypes and Prognostic Characteristics of Lung Adenocarcinoma Based on Pentose Phosphate Metabolic Pathway-Related Long Non-coding RNAs.基于戊糖磷酸代谢途径相关长非编码 RNA 鉴定肺腺癌的两种亚型和预后特征。
Front Public Health. 2022 Jun 21;10:902445. doi: 10.3389/fpubh.2022.902445. eCollection 2022.
6
Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma.鉴定脂肪酸代谢相关长链非编码RNA作为肺腺癌患者临床预后和免疫治疗反应的生物标志物
Front Genet. 2022 Apr 8;13:855940. doi: 10.3389/fgene.2022.855940. eCollection 2022.
7
Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma.血浆代谢组学揭示食管鳞状细胞癌的诊断生物标志物和风险因素。
Front Oncol. 2022 Feb 7;12:829350. doi: 10.3389/fonc.2022.829350. eCollection 2022.
8
LDH-A inhibitors as remedies to enhance the anticancer effects of PARP inhibitors in ovarian cancer cells.LDH-A 抑制剂作为增敏剂增强 PARP 抑制剂在卵巢癌细胞中的抗癌作用。
Aging (Albany NY). 2021 Dec 16;13(24):25920-25930. doi: 10.18632/aging.203780.
9
Machine learning meets omics: applications and perspectives.机器学习与组学的融合:应用与展望。
Brief Bioinform. 2022 Jan 17;23(1). doi: 10.1093/bib/bbab460.
10
Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma.从癌前病变到浸润性肺腺癌的进化代谢景观。
Nat Commun. 2021 Nov 10;12(1):6479. doi: 10.1038/s41467-021-26685-y.